Brian Mullan

Chief Technical Officer, Cell and Gene Therapies, Yposkesi

Brian is Chief Technical Officer at Yposkesi, where he leads analytical and process development activities, process industrialisation and technological innovation.

Yposkesi is a leading CDMO focused on the development and production of cell and gene therapy vectors (AAV, Lentivirus) for human use, and is based in Corbeil-Essonnes (south of Paris), France.
Brian has wide experience in process development, product management and commercialisation of biologics, having previously worked for Janssen Biologics, Eli Lilly and Novartis.

Prior to joining Yposkesi, he was Head, Manufacturing Science and Technology for a Novartis biologics manufacturing site. He holds a degree in Biochemistry, a PhD in Viral Genetics, and an MBA.